"Empresa dedicada al desarrollo de medicamentos ,vacunas, tratamientos y dispositivos médicos para mejorar la salud y calidad de vida en seres humanos de diferentes edades. Todo hecho con humanismo,ética y enfocado en el bienestar de la investigación clínica"

During the past decade, Cemdeicy S.C.P. conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cemdeicy S.C.P." #1 sponsor was "Pfizer" with 5 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "EMD Serono" with 1 trials sponsored and "Fresenius Kabi SwissBioSim GmbH" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cemdeicy S.C.P." #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cemdeicy S.C.P." are "Atopic Dermatitis" (2 trials), "Psoriatic Arthritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "COVID-19" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Cemdeicy S.C.P." in a lesser frequency.

Most popular intervention types in "Cemdeicy S.C.P." are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Adalimumab" (2 trials), "Baricitinib" (2 trials), "9vHPV vaccine" (1 trials) and "Abrocitinib 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cemdeicy S.C.P." are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cemdeicy S.C.P.". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Cemdeicy S.C.P., 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cemdeicy S.C.P., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".